ENG and glioblastoma: The aim of this study is to develop the CD105-targeted MBs and investigate the potential of molecular US for the noninvasive assessment of the expression levels of endoglin (CD105) during glioblastoma progression from small to large sizes in vivo, as illustrated in Figure 1.